References
- Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975–2010. Bethesda, MD: National Cancer Institute. Available at: http://seer.cancer.gov/csr/1975_2010/ [Last accessed 5 March 2015]
- National Comprehensive Cancer Network. NCCN Guidelines for Patients: Melanoma. Version 1, 2014. Available at: http://ww.nccn.org/patients/guidelines/melanoma/files/assets/basic-html/index.html#1 [Last accessed 5 March 2015]
- National Cancer Institute. NCI Cancer Drug Information: Drugs Approved for Melanoma. Available at: http://www.cancer.gov/cancertopics/druginfo/melanoma [Last accessed 5 March 2015]
- National Cancer Institute. FDA Approval for Ipilimumab. Available at: http://www.cancer.gov/cancertopics/druginfo/fda-ipilimumab [Last accessed 5 March 2015]
- National Cancer Institute. FDA Approval for Vemurafenib. Available at: http://www.cancer.gov/cancertopics/druginfo/fda-vemurafenib [Last accessed 5 March 2015]
- Surveillance, Epidemiology, and End Results. Available at: http://seer.cancer.gov/ [Last accessed 5 March 2015]
- National Cancer Institute. SEER as a Research Resource. 2010. Available at: http://seer.cancer.gov/about/factsheets/SEER_Research_Brochure.pdf [Last accessed 5 March 2015]
- National Cancer Institute. Data Flow in NCI’s SEER Registries. 2011. Available at: http://seer.cancer.gov/about/factsheets/SEER_Data_Flow_.pdf [Last accessed 5 March 2015]
- National Cancer Institute. SEER Program Coding and Staging Manual. 2013. Available at: http://seer.cancer.gov/manuals/2013/SPCSM_2013_maindoc.pdf [Last accessed 5 March 2015]
- Surveillance, Epidemiology, and End Results (SEER) Program Research Data (1973–2009), National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2012, based on the November 2011 submission. Available at: www.seer.cancer.gov [Last accessed 5 March 2015]
- SEER Research Data Record Description Cases Diagnosed in 1973–2009. 2012. Available at: http://seer.cancer.gov/data/seerstat/nov2011/TextData.FileDescription.pdf [Last accessed 5 March 2015]
- Surveillance, Epidemiology and End Results. SEER Stat Fact Sheets: Melanoma of the Skin. Available at: http://seer.cancer.gov/statfacts/html/melan.html [Last accessed 5 March 2015]
- Lai SM, King JB, Garimella S, et al. Effect of the staging schema on melanoma cancer reporting, 1999 to 2006. J Am Acad Dermatol 2011;65(5 Suppl 1):S95-103
- Pollack LA, Li J, Berkowitz Z, et al. Melanoma survival in the United States, 1992 to 2005. J Am Acad Dermatol 2011;65(5 Suppl 1):S78-86
- Xing Y, Chang GJ, Hu CY, et al. Conditional survival estimates improve over time for patients with advanced melanoma: results from a population-based analysis. Cancer 2010;116:2234-41
- Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001;19:3635-48
- Yu JB, Gross CP, Wilson LD, Smith BD. NCI SEER public-use data: applications and limitations in oncology research. Oncology (Williston Park) 2009;23:288-95